Matt Krisiloff

More founders and investors debating China’s rise should go and visit In June, I spent two weeks in Shanghai, Shenzhen, and Hong Kong meeting dozens of biotech founders, scientists, professors, investors, CEOs, and clinicians.

At this point in my career across the biotech-related projects I’ve run, I’ve personally raised about $100 million.

One thing I’ve been surprised about since starting SciFounders is how many of the founders we talk to are coming from academia rather than from industry.

One thing I’ve been surprised about since starting SciFounders is how many of the founders we talk to are coming from academia rather than from industry.

One of the biggest differences between the software startup world (where I used to spend most of my time) and the science startup world is how little most scientists seem to value company equity.

It seems amongst many scientists that the idea of starting a company is still looked down upon.

Earlier this year, my teammates and I interviewed over 100 teams for the first cohort of SciFounder Fellowship, and by far the most frequent issues we noticed were problematic equity splits amongst teammates.